I Peace, Inc. is a Palo Alto- and Kyoto-based biotech that mass-manufactures clinical-grade induced pluripotent stem cells (iPSCs) using a proprietary automated, closed-cassette platform. Founded in 2015 by Koji Tanabe - a co-author of the world's first human iPSC paper from Shinya Yamanaka's Nobel Prize-winning lab - the company operates as a CDMO supplying GMP-grade iPSCs to pharmaceutical companies, biotechs, and research institutions, and offers personal iPSC banking and longevity services that aim to make cell therapy affordable and accessible.
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) for cell therapy. Its Cell Shuttle - a fully automated, high-throughput platform roughly the size of a small conference room - replaces a warren of manual labs with one box that can run 16 patient batches in parallel, cutting labor and facility footprint by about 90 percent.